Fmr LLC Cuts Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

FMR LLC decreased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 56.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 438,149 shares of the company's stock after selling 566,804 shares during the period. FMR LLC owned 0.89% of Prestige Consumer Healthcare worth $31,591,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Quest Partners LLC lifted its stake in Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company's stock worth $30,000 after acquiring an additional 424 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in Prestige Consumer Healthcare by 562.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company's stock worth $35,000 after buying an additional 433 shares in the last quarter. Gladius Capital Management LP purchased a new position in shares of Prestige Consumer Healthcare during the 2nd quarter worth approximately $35,000. ORG Partners LLC bought a new position in shares of Prestige Consumer Healthcare in the 2nd quarter worth approximately $39,000. Finally, nVerses Capital LLC lifted its stake in shares of Prestige Consumer Healthcare by 200.0% in the 3rd quarter. nVerses Capital LLC now owns 600 shares of the company's stock valued at $43,000 after purchasing an additional 400 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PBH has been the subject of a number of research reports. Jefferies Financial Group reiterated a "hold" rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reissued a "buy" rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. Finally, Sidoti cut shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective on the stock. in a report on Monday. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $85.25.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, insider William P'pool sold 8,987 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total transaction of $735,585.95. Following the completion of the sale, the insider now owns 20,058 shares of the company's stock, valued at $1,641,747.30. The trade was a 30.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Ronald M. Lombardi sold 10,875 shares of the firm's stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the transaction, the chief executive officer now directly owns 320,952 shares in the company, valued at approximately $26,510,635.20. This represents a 3.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 38,810 shares of company stock worth $3,187,300 in the last three months. 1.60% of the stock is currently owned by company insiders.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE PBH traded down $1.05 during trading on Monday, reaching $83.28. 249,832 shares of the company traded hands, compared to its average volume of 251,315. The firm has a 50 day simple moving average of $77.01 and a 200-day simple moving average of $72.05. Prestige Consumer Healthcare Inc. has a 52-week low of $57.95 and a 52-week high of $86.36. The stock has a market capitalization of $4.11 billion, a PE ratio of 20.26, a P/E/G ratio of 2.37 and a beta of 0.49. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm had revenue of $283.79 million for the quarter, compared to analysts' expectations of $282.09 million. During the same period in the prior year, the firm earned $1.07 EPS. The company's revenue was down .9% compared to the same quarter last year. Equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.44 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.